L J Jara|L R Espinoza - JoVE Visualize

Showing results (1-10 of 157) with videos related to

Pageof 16

Sort By:

Lupus|January 1, 1997

Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patientsL J Jara, C Prasad, L R Espinoza

Clinical Rheumatology|June 26, 1998

Prolactin and interleukin-6 in neuropsychiatric lupus erythematosusL J Jara, L Irigoyen, M J Ortiz, et al.

The Journal of Rheumatology|July 1, 1994

Hyperprolactinemia in Reiter's syndromeL J Jara, L H Silveira, M L Cuéllar, et al.

Rheumatic Diseases Clinics of North America|February 1, 1992

There is an association between human immunodeficiency virus infection and spondyloarthropathiesL R Espinoza, L J Jara, C G Espinoza, et al.

Lupus|February 1, 1993

Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapyL R Espinoza, L J Jara, P Martinez-Osuna, et al.

The American Journal of the Medical Sciences|April 1, 1992

Hyperprolactinemia in systemic lupus erythematosus: association with disease activityL J Jara, C Gomez-Sanchez, L H Silveira, et al.

The American Journal of Medicine|April 1, 1991

Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complicationsL R Espinoza, L J Jara, L H Silveira, et al.

Seminars in Arthritis and Rheumatism|October 1, 1991

Treatment of the eosinophilia-myalgia syndromeP Martínez-Osuna, P M Wallach, M J Seleznick, et al.

Clinical and Experimental Rheumatology|May 1, 1993

Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritisP Martínez-Osuna, J B Zwolinska, D H Sikes, et al.

Lupus|October 1, 1995

Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activityM A Gutiérrez, J F Molina, L J Jara, et al.

Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:

Pageof 16

Lupus|January 1, 1997

Elevated serum levels of cyclo (His-Pro), an endogenous inhibitor of pituitary prolactin secretion, in systemic lupus erythematosus patientsL J Jara, C Prasad, L R Espinoza

Clinical Rheumatology|June 26, 1998

Prolactin and interleukin-6 in neuropsychiatric lupus erythematosusL J Jara, L Irigoyen, M J Ortiz, et al.

The Journal of Rheumatology|July 1, 1994

Hyperprolactinemia in Reiter's syndromeL J Jara, L H Silveira, M L Cuéllar, et al.

Rheumatic Diseases Clinics of North America|February 1, 1992

There is an association between human immunodeficiency virus infection and spondyloarthropathiesL R Espinoza, L J Jara, C G Espinoza, et al.

Lupus|February 1, 1993

Refractory nephrotic syndrome in lupus nephritis: favorable response to indomethacin therapyL R Espinoza, L J Jara, P Martinez-Osuna, et al.

The American Journal of the Medical Sciences|April 1, 1992

Hyperprolactinemia in systemic lupus erythematosus: association with disease activityL J Jara, C Gomez-Sanchez, L H Silveira, et al.

The American Journal of Medicine|April 1, 1991

Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complicationsL R Espinoza, L J Jara, L H Silveira, et al.

Seminars in Arthritis and Rheumatism|October 1, 1991

Treatment of the eosinophilia-myalgia syndromeP Martínez-Osuna, P M Wallach, M J Seleznick, et al.

Clinical and Experimental Rheumatology|May 1, 1993

Lack of immunosuppressive effect of low-dose oral methotrexate on lymphocytes in rheumatoid arthritisP Martínez-Osuna, J B Zwolinska, D H Sikes, et al.

Lupus|October 1, 1995

Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activityM A Gutiérrez, J F Molina, L J Jara, et al.

Pageof 16